89.79
price down icon1.09%   -0.99
after-market Dopo l'orario di chiusura: 89.79
loading
Precedente Chiudi:
$90.78
Aprire:
$91.05
Volume 24 ore:
173.71K
Relative Volume:
0.38
Capitalizzazione di mercato:
$1.95B
Reddito:
$486.82M
Utile/perdita netta:
$18.78M
Rapporto P/E:
109.50
EPS:
0.82
Flusso di cassa netto:
$100.45M
1 W Prestazione:
+0.17%
1M Prestazione:
-7.87%
6M Prestazione:
+37.88%
1 anno Prestazione:
+62.96%
Intervallo 1D:
Value
$89.31
$91.47
Intervallo di 1 settimana:
Value
$89.13
$92.56
Portata 52W:
Value
$52.50
$99.50

Ani Pharmaceuticals Inc Stock (ANIP) Company Profile

Name
Nome
Ani Pharmaceuticals Inc
Name
Telefono
(218) 634-3500
Name
Indirizzo
210 MAIN STREET WEST, BAUDETTE, MN
Name
Dipendente
897
Name
Cinguettio
Name
Prossima data di guadagno
2025-08-08
Name
Ultimi documenti SEC
Name
ANIP's Discussions on Twitter

Confronta ANIP con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Drug Manufacturers - Specialty & Generic icon
ANIP
Ani Pharmaceuticals Inc
89.79 2.02B 486.82M 18.78M 100.45M 0.82
Drug Manufacturers - Specialty & Generic icon
ZTS
Zoetis Inc
141.11 63.55B 9.39B 2.62B 2.22B 5.8121
Drug Manufacturers - Specialty & Generic icon
TAK
Takeda Pharmaceutical Co Adr
13.71 44.47B 29.96B 957.25M 4.77B 0.2956
Drug Manufacturers - Specialty & Generic icon
HLN
Haleon Plc Adr
9.00 40.17B 14.26B 1.98B 2.47B 0.4327
Drug Manufacturers - Specialty & Generic icon
TEVA
Teva Pharmaceutical Industries Ltd Adr
20.03 22.99B 16.70B -157.13M 1.19B -0.1446
Drug Manufacturers - Specialty & Generic icon
UTHR
United Therapeutics Corp
440.00 20.14B 3.08B 1.24B 1.07B 25.61

Ani Pharmaceuticals Inc Stock (ANIP) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2025-07-10 Iniziato H.C. Wainwright Buy
2025-03-14 Iniziato Jefferies Buy
2025-03-12 Iniziato JP Morgan Overweight
2024-12-11 Iniziato Leerink Partners Outperform
2024-10-11 Iniziato Piper Sandler Overweight
2024-03-15 Iniziato CapitalOne Overweight
2023-08-22 Reiterato H.C. Wainwright Buy
2023-03-01 Iniziato Guggenheim Buy
2022-09-07 Iniziato H.C. Wainwright Buy
2021-11-02 Iniziato Truist Buy
2020-05-07 Downgrade Cantor Fitzgerald Overweight → Neutral
2019-09-12 Iniziato Guggenheim Buy
2019-05-10 Downgrade Raymond James Strong Buy → Outperform
2017-10-16 Reiterato Canaccord Genuity Buy
2017-07-31 Iniziato Canaccord Genuity Buy
2017-02-22 Downgrade ROTH Capital Buy → Neutral
2016-06-23 Iniziato Raymond James Strong Buy
2016-05-24 Downgrade Standpoint Research Buy → Hold
2015-11-13 Iniziato Standpoint Research Buy
2015-09-28 Aggiornamento ROTH Capital Neutral → Buy
2015-08-05 Reiterato Oppenheimer Outperform
2015-08-04 Reiterato ROTH Capital Neutral
2015-07-31 Reiterato Oppenheimer Outperform
2015-07-15 Reiterato ROTH Capital Neutral
2015-06-23 Reiterato Oppenheimer Outperform
2015-05-18 Reiterato ROTH Capital Neutral
2015-05-06 Reiterato Oppenheimer Outperform
2015-04-10 Downgrade ROTH Capital Buy → Neutral
2015-02-26 Reiterato ROTH Capital Buy
2015-02-18 Reiterato Oppenheimer Outperform
Mostra tutto

Ani Pharmaceuticals Inc Borsa (ANIP) Ultime notizie

pulisher
Oct 10, 2025

Is ANI Pharmaceuticals Inc. a candidate for recovery play2025 Buyback Activity & Verified Short-Term Trading Plans - newser.com

Oct 10, 2025
pulisher
Oct 10, 2025

Truist Financial Issues Positive Forecast for ANI Pharmaceuticals (NASDAQ:ANIP) Stock Price - MarketBeat

Oct 10, 2025
pulisher
Oct 10, 2025

Visualizing ANI Pharmaceuticals Inc. stock with heatmaps2025 Price Targets & Weekly High Momentum Picks - newser.com

Oct 10, 2025
pulisher
Oct 10, 2025

Are Medical Stocks Lagging ANI Pharmaceuticals (ANIP) This Year? - Yahoo Finance

Oct 10, 2025
pulisher
Oct 10, 2025

ANI Pharmaceuticals Inc. stock trend forecastTrade Signal Summary & Daily Technical Forecast Reports - newser.com

Oct 10, 2025
pulisher
Oct 10, 2025

What recovery options are there for ANI Pharmaceuticals Inc.Portfolio Growth Summary & Weekly Top Gainers Trade List - newser.com

Oct 10, 2025
pulisher
Oct 10, 2025

Will a bounce in ANI Pharmaceuticals Inc. offer an exitQuarterly Risk Review & Low Volatility Stock Recommendations - newser.com

Oct 10, 2025
pulisher
Oct 10, 2025

How ANI Pharmaceuticals Inc. (BSFA) stock compares with tech leaders2025 Price Momentum & Consistent Income Trade Ideas - newser.com

Oct 10, 2025
pulisher
Oct 09, 2025

Analyzing recovery setups for ANI Pharmaceuticals Inc. investors2025 Year in Review & Technical Confirmation Trade Alerts - newser.com

Oct 09, 2025
pulisher
Oct 09, 2025

Will ANI Pharmaceuticals Inc. (BSFA) stock beat value stocksQuarterly Profit Report & Pattern Based Trade Signal System - newser.com

Oct 09, 2025
pulisher
Oct 09, 2025

Is ANI Pharmaceuticals Inc. stock undervalued vs historical averages2025 Earnings Surprises & Fast Momentum Entry Tips - newser.com

Oct 09, 2025
pulisher
Oct 08, 2025

ANI Pharmaceuticals (NASDAQ:ANIP) Downgraded to "Sell (D+)" Rating by Weiss Ratings - MarketBeat

Oct 08, 2025
pulisher
Oct 07, 2025

ANI Pharmaceuticals (ANIP): Buy, Sell, Or Hold Post Q2 Earnings? - Barchart.com

Oct 07, 2025
pulisher
Oct 07, 2025

ANI Pharmaceuticals (ANIP): Buy, Sell, or Hold Post Q2 Earnings? - The Globe and Mail

Oct 07, 2025
pulisher
Oct 06, 2025

Can ANI Pharmaceuticals Inc. stock deliver strong Q4 earnings2025 Technical Patterns & Risk Managed Investment Signals - newser.com

Oct 06, 2025
pulisher
Oct 06, 2025

Institutional scanner results for ANI Pharmaceuticals Inc.Bond Market & Low Drawdown Trading Strategies - newser.com

Oct 06, 2025
pulisher
Oct 05, 2025

Can ANI Pharmaceuticals Inc. stock sustain revenue growth2025 Geopolitical Influence & Real-Time Chart Pattern Alerts - newser.com

Oct 05, 2025
pulisher
Oct 03, 2025

Live market analysis of ANI Pharmaceuticals Inc.Weekly Gains Summary & Technical Buy Zone Confirmations - newser.com

Oct 03, 2025
pulisher
Oct 03, 2025

Is a relief rally coming for ANI Pharmaceuticals Inc. holdersWeekly Investment Report & Weekly Top Gainers Alerts - newser.com

Oct 03, 2025
pulisher
Oct 01, 2025

What moving averages say about ANI Pharmaceuticals Inc.Short Setup & Fast Gain Stock Trading Tips - newser.com

Oct 01, 2025
pulisher
Sep 29, 2025

A Fresh Look at ANI Pharmaceuticals (ANIP) Valuation as Quiet Market Moves Draw Investor Interest - Yahoo Finance

Sep 29, 2025
pulisher
Sep 28, 2025

What analysts say about ANI Pharmaceuticals Inc stockLong-Term Investment Plans & Swing Trade Smarter With Data Insights - earlytimes.in

Sep 28, 2025
pulisher
Sep 28, 2025

Assenagon Asset Management S.A. Sells 101,728 Shares of ANI Pharmaceuticals, Inc. $ANIP - MarketBeat

Sep 28, 2025

Ani Pharmaceuticals Inc Azioni (ANIP) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading

Ani Pharmaceuticals Inc Azioni (ANIP) insider trading

Commercio interno Relazione Data Transazione Costo #Azioni Valore ($) #Azioni Totale
Cook Meredith
SR. VP, GENERAL COUNSEL & SEC.
Sep 12 '25
Sale
98.42
400
39,368
76,074
Pera Antonio R
Director
Sep 03 '25
Sale
94.94
7,292
692,302
22,660
$19.76
price down icon 1.54%
$9.74
price down icon 2.50%
$53.95
price down icon 7.38%
drug_manufacturers_specialty_generic RDY
$14.34
price up icon 1.20%
$136.63
price down icon 1.33%
$440.00
price down icon 1.21%
Capitalizzazione:     |  Volume (24 ore):